Next Article in Journal
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
Next Article in Special Issue
A Review of Topical Diclofenac Use in Musculoskeletal Disease
Previous Article in Journal
Role of Leukotrienes and Leukotriene Modifiers in Asthma
Previous Article in Special Issue
The Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in the Management of the Post-Embolization Symptoms after Uterine Artery Embolization
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(6), 1812-1841; doi:10.3390/ph3061812

Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

Department of Biology, Carleton College, one north college street, Northfield, MN 55057, USA
*
Author to whom correspondence should be addressed.
Received: 8 April 2010 / Revised: 10 May 2010 / Accepted: 2 June 2010 / Published: 2 June 2010
(This article belongs to the Collection Non-Steroidal Anti-Inflammatory Drugs)
View Full-Text   |   Download PDF [867 KB, uploaded 2 June 2010]   |  

Abstract

Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases with age as the greatest risk factor. As the general population experiences extended life span, preparation for the prevention and treatment of these and other age-associated neurological diseases are warranted. Since epidemiological studies suggested that non-steroidal anti-inflammatory drug (NSAID) use decreased risk for AD and PD, increasing attention has been devoted to understanding the costs and benefits of the innate neuroinflammatory response to functional recovery following pathology onset. This review will provide a general overview on the role of neuroinflammation in these neurodegenerative diseases and an update on NSAID treatment in recent experimental animal models, epidemiological analyses, and clinical trials. View Full-Text
Keywords: Non-steroidal anti-inflammatory drugs; Alzheimer's disease; Parkinson's disease; cyclooxygenase; neuroinflammation Non-steroidal anti-inflammatory drugs; Alzheimer's disease; Parkinson's disease; cyclooxygenase; neuroinflammation
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Moore, A.H.; Bigbee, M.J.; Boynton, G.E.; Wakeham, C.M.; Rosenheim, H.M.; Staral, C.J.; Morrissey, J.L.; Hund, A.K. Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation. Pharmaceuticals 2010, 3, 1812-1841.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top